Didier Merlin

Publishes on Inflammatory Bowel Disease, Helicobacter pylori-related gastroenterology studies, Drug Transport and Resistance Mechanisms. 407 papers and 19.3k citations.

PubIndex Score98Top 2%How it's scored

🌟#3 Current Senior Leader in Ginger and Zingiberaceae research

407Publications

19.3kTotal Citations

#3in Ginger and Zingiberaceae research

First publication: 1994First senior author: 2002

Inflammatory Bowel Disease Helicobacter pylori-related gastroenterology studies Drug Transport and Resistance Mechanisms Nanoparticle-Based Drug Delivery RNA Interference and Gene Delivery

Top publicationsby citations

Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer

Mingzhen Zhang, Didier Merlin, Lixin Wang et al.|Biomaterials|2016

Cited by 957

<p>Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives</p>

Chunhua Yang, Didier Merlin|International Journal of Nanomedicine|2019

Cited by 183

Silencing of Intestinal Glycoprotein CD98 by Orally Targeted Nanoparticles Enhances Chemosensitization of Colon Cancer

Bo Xiao, Didier Merlin, Émilie Viennois et al.|ACS Nano|2018

Cited by 113

Nuclear Factor-κB Is a Critical Mediator of Ste20-Like Proline-/Alanine-Rich Kinase Regulation in Intestinal Inflammation

Yutao Yan, Didier Merlin|American Journal Of Pathology|2008

Cited by 48

Isolation, Purification, and Characterization of Ginger-derived Nanoparticles (GDNPs) from Ginger, Rhizome of Zingiber officinale

Jun-Sik Jung, Didier Merlin|BIO-PROTOCOL|2019

Cited by 34